Serum Ig Levels in JAK3-Deficient Patients Post-BMT
Patient . | Age at Evaluation Yr . | IgGIgAIgM . | IgE . | ||
---|---|---|---|---|---|
mg/dL . | IU/mL . | ||||
2 | 8.5 | 389 | 17 | 127 | 39 |
(600-1,500) | (50-200) | (50-200) | (0-200) | ||
3 | 1.4 | 569 | 12 | 105 | 1 |
(400-1,300) | (20-230) | (30-120) | (0-30) | ||
5 | 23.5 | 586 | 168 | 145 | 5,985 |
(600-1,500) | (50-200) | (50-200) | (0-200) |
Patient . | Age at Evaluation Yr . | IgGIgAIgM . | IgE . | ||
---|---|---|---|---|---|
mg/dL . | IU/mL . | ||||
2 | 8.5 | 389 | 17 | 127 | 39 |
(600-1,500) | (50-200) | (50-200) | (0-200) | ||
3 | 1.4 | 569 | 12 | 105 | 1 |
(400-1,300) | (20-230) | (30-120) | (0-30) | ||
5 | 23.5 | 586 | 168 | 145 | 5,985 |
(600-1,500) | (50-200) | (50-200) | (0-200) |
Serum Ig levels were assessed in the three patients who were not receiving gamma globulin replacement. IgG, A, and M were measured by radial immunodiffusion, and IgE by fluoroenzymatic immuno assay. Normal values for each age are indicated in brackets parentheses.